Souhil Lebdai

About

Souhil Lebdai is a urological surgeon and researcher whose work centers on advancing minimally invasive treatments for prostate cancer and benign prostatic hyperplasia (BPH). His major contributions lie in evaluating the feasibility and outcomes of novel surgical and interventional techniques. Notably, his 2018 study on radical prostatectomy following vascular targeted photodynamic therapy with Padeliporfin—a cutting-edge treatment for localized prostate cancer—demonstrated its surgical feasibility and provided early functional and oncologic results, earning 26 citations. Lebdai also addresses the challenge of managing large-volume BPH, comparing endoscopic enucleation versus robotic-assisted simple prostatectomy for prostates over 150 cm³ in a 2025 study. Additionally, his 2020 review synthesizes emerging techniques for bladder outlet obstruction due to BPH. Through these works, Lebdai helps define best practices for complex urological conditions, bridging innovation with clinical application. His research is essential reading for urologists and trainees navigating the evolving landscape of prostate care.

Research Focus

Key Achievements

Top Papers

1. 1
   Radical Prostatectomy after Vascular Targeted Photodynamic Therapy with Padeliporfin: Feasibility, and Early and Intermediate Results

   26 citations · 2018
2. 2
   Mise au point sur les nouvelles techniques chirurgicales et interventionnelles dans la prise en charge de l’obstruction sous-vésicale liée à l’hyperplasie bénigne de la prostate

   5 citations · 2020
3. 3
   Benign prostate hyperplasia over 150 cm3: Should we perform an endoscopic enucleation of the prostate or robotic-assisted simple prostatectomy?

   2 citations · 2025

Key Collaborators

Contact & Links